Study of HRS9432 for blood or organ yeast infection
Part of Infections clinical trials.
This trial tests a new antifungal drug, HRS9432, for patients with candidemia (a yeast infection in the blood) or invasive candidiasis (yeast infection in organs). It aims to see if the drug is safe and works well for these serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a confirmed or suspected yeast infection in your blood or organs (candidemia or invasive candidiasis)
- You have had at least one symptom of the infection in the past 4 days
- You or your partner agree to use effective birth control during the study and for 6 months after treatment
- You are willing and able to sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a shorter course of the antifungal caspofungin (7 days total) is as effective as the usual longer treatment for people with uncomplicated candidemia, a yeast infection in the blood. Participating patients must already be on caspofungin and have shown clear blood cultures for 7 days.
This trial tests BSG005, a new IV medicine for patients with invasive fungal infections that haven't improved with standard treatment or can't use standard treatments due to side effects or resistance. The goal is to see if it's safe and effective.
This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.
This study tests whether a shorter course of antifungal medication works as well as the standard longer course for patients with a yeast infection in the blood (candidemia) that is not complicated by spread to other organs. If you have cleared the infection from your blood and are fever-free, you may be able to stop treatment sooner.
This study looks at patients in the intensive care unit who have a new infection with Candida (a type of fungus) despite taking strong antibiotics. It aims to better understand and diagnose these serious infections.
This trial compares shorter vs longer treatment for children with an uncomplicated yeast (Candida) bloodstream infection once blood cultures are clear. It may help reduce medicine exposure while keeping the infection under control.
Hear when a new Patients With Candidemia and/or Invasive Candidiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.